Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Cardiogenic versus non-cardiogenic pulmonary oedema

Respiratory · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Severe respiratory distress, frothy sputum, cyanosis, altered consciousness, shock or rapidly escalating oxygen need is a resuscitation emergency. Use ABCDE care, sit the patient upright when tolerated, provide monitored oxygen or ventilatory support, obtain senior cardiac and critical-care help, and treat immediately reversible causes; do not delay support while debating cardiogenic versus non-cardiogenic labels.

Synopsis

Stabilise acute pulmonary oedema, distinguish raised hydrostatic pressure from permeability injury using bedside physiology and targeted tests, and treat the mechanism rather than the radiograph alone.

  • Cardiogenic oedema results mainly from raised pulmonary capillary hydrostatic pressure; non-cardiogenic oedema reflects increased alveolar–capillary permeability, as in ARDS.
  • Orthopnoea, raised JVP, peripheral oedema, ischaemia, hypertension, new murmur or known ventricular disease support cardiogenic physiology, but overlap is common.
  • Sepsis, aspiration, pancreatitis, transfusion, trauma or inhalational injury with bilateral opacities and no dominant left-heart failure suggests non-cardiogenic injury.
  • Chest radiography can show bat-wing shadowing, septal lines, cardiomegaly or effusions in cardiogenic oedema; ARDS more often has diffuse opacities without cardiomegaly, but no sign is definitive.
  • Lung ultrasound confirms interstitial fluid through B-lines but cannot alone establish its cause. Add focused cardiac ultrasound, IVC context and the clinical story.
  • Natriuretic peptides support heart-failure assessment but rise with age, renal dysfunction, right-heart strain and critical illness; low values are more useful for reducing likelihood than high values are for proving cause.
  • Give intravenous loop diuretic promptly in acute heart failure with congestion and monitor renal function, weight and urine output. Do not use diuresis reflexively in permeability oedema with shock.
  • NICE advises against routine nitrates, opiates or non-invasive ventilation for every acute-heart-failure patient. Use NIV for severe dyspnoea with acidaemia or failure of initial treatment, and nitrates only in selected circumstances.
  • Non-cardiogenic oedema management centres on source control, lung-protective support and a conservative fluid strategy after shock has resolved.
  • Repeated reassessment matters because mixed cardiogenic and inflammatory oedema is common, especially in older people with sepsis and cardiac disease.

Key red flags

Cardiogenic pulmonary oedema

Acute orthopnoea, widespread crackles, raised JVP, oedema, cool or hypertensive physiology, cardiomegaly, effusions and a compatible cardiac trigger make hydrostatic oedema likely.

Flash pulmonary oedema

Abrupt severe distress with hypertension may follow acute ischaemia, rapid arrhythmia, renal-artery disease or acute mitral/aortic valve dysfunction; little peripheral oedema may be present.

Non-cardiogenic permeability oedema

A recognised inflammatory insult, bilateral opacities, hypoxaemia disproportionate to congestion and no dominant left-heart failure suggests ARDS or another permeability process.

Mixed oedema

Sepsis, renal disease, transfusion or major surgery can combine ventricular dysfunction, fluid loading and inflammatory capillary leak; discordant findings should prompt a mixed model rather than forced categorisation.

Important mimic

Bilateral pneumonia, diffuse alveolar haemorrhage, lymphangitic cancer, acute eosinophilic pneumonia and severe interstitial-lung-disease exacerbation can resemble oedema radiographically.

Cardiogenic shock

Hypotension, cool peripheries, confusion, oliguria and elevated lactate with pulmonary congestion indicate low output; standard diuretic or vasodilator treatment alone may worsen perfusion.

Investigation priorities

01
ABCDE assessment, pulse oximetry and arterial blood gasFirst step

Quantify immediate respiratory and circulatory failure and identify hypercapnia, acidosis or lactate elevation.

Management branches

First minutesStabilise before classifying

Acute respiratory distress with bilateral crackles or pulmonary opacities.

  1. Sit upright if tolerated, attach monitoring, obtain IV access, prescribe oxygen to target and call senior help while assessing airway, breathing and circulation.
  2. Use CPAP or NIV when severe dyspnoea with acidaemia persists or initial treatment fails, with immediate intubation planning if consciousness, shock or work of breathing worsens.
  3. Obtain ECG, portable chest radiograph, blood gas, renal profile, troponin and focused ultrasound without delaying treatment.
  4. Identify a trigger: ACS, arrhythmia, hypertensive emergency, valve catastrophe, infection, aspiration, transfusion, renal failure or toxin.

Key medicines

Intravenous loop diureticStart promptly for acute heart failure with congestion, selecting dose from prior diuretic exposure, renal function and the current local protocol.Monitor urine output, weight, creatinine, sodium, potassium and blood pressure. Do not assume oliguria means more diuretic when shock or intravascular depletion is present.
Intravenous nitrate for selected patientsUse a titrated monitored infusion only for a defined indication such as severe hypertension, ischaemia or acute regurgitation and adequate blood pressure.NICE does not recommend routine nitrate use. Avoid with hypotension, right-ventricular infarction, severe aortic stenosis or recent PDE5 inhibitor exposure.
Open full textbook →Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE CG187 acute heart failure recommendationsDiagnosis, intravenous diuretics, ventilation, nitrates and monitoring recommendations.
  • BTS guideline for emergency oxygen useTarget-saturation and blood-gas safety guidance.
  • ICS and FICM ARDS guidelineNon-cardiogenic oedema, lung-protective ventilation and fluid strategy.
  • NICE NG253 suspected sepsis in people aged 16 or over — managing suspected sepsisCurrent source-control, antimicrobial and resuscitation framework for a common precipitant.
  • BNF furosemide monographCurrent route, dose, contraindication, interaction and monitoring source.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom